Skip to content

Supplier News

Allergan announces pair of biopharma acquisitions

Allergan announces pair of biopharma acquisitions

Chalk up three acquisitions for Allergan plc in less than a week. On Tuesday, Allergan said it plans to purchase clinical-stage biopharmaceutical company Tobira Therapeutics Inc. in an agreement valued at up to $1.695 billion.

U by Kotex expands Security Ultra Thin pad line

U by Kotex expands Security Ultra Thin pad line

U by Kotex has rolled out two new products, Security Ultra Thin Pads Long and Security Ultra Thin Overnight Pads. The Kimberly-Clark feminine care brand said Tuesday that its latest offerings expand its line of “unique, colorful and bold” products to fit women’s “period needs.

GlaxoSmithKline tabs consumer health chief as CEO

GlaxoSmithKline tabs consumer health chief as CEO

Emma Walmsley has been named to succeed Sir Andrew Witty as chief executive officer of GlaxoSmithKline plc. The drug maker said Tuesday that Walmsley, CEO of GSK Consumer Healthcare, is slated to take the reins from Witty when he retires on March 31, 2017. Plans call for her to become a member of

Unilever strikes deal to buy Seventh Generation

Unilever strikes deal to buy Seventh Generation

Consumer products giant Unilever plans to acquire eco-friendly household and personal care products maker Seventh Generation Inc. Financial terms of the agreement weren’t disclosed. Unilever said completion transaction is pending regulatory approvals. Unilever described Burlington, Vt.

Amneal set to release Yuvafem

Amneal set to release Yuvafem

Amneal Pharmaceuticals LLC next month plans to begin shipping Yuvafem 10-mcg estradiol vaginal inserts, a treatment for menopausal symptoms. Amneal said Monday that its product represents the first generic equivalent of Vagifem from Novo Nordisk.

Glenmark cleared to market Xylocaine generic

Glenmark cleared to market Xylocaine generic

Glenmark Pharmaceuticals Inc. USA has received final approval from the Food and Drug Administration for lidocaine ointment 5%. Glemark said its product is a generic version of Xylocaine ointment 5% from AstraZeneca.

Amneal adds to women’s health lineup

Amneal adds to women’s health lineup

Amneal Pharmaceuticals LLC has expanded its portfolio of women’s health products with the release of Femynor, a birth control pill. Amneal said Femynor (norgestimate and ethinyl estradiol tablets, 0.25 mg/0.

Revlon closes Elizabeth Arden acquisition

Revlon closes Elizabeth Arden acquisition

Revlon Inc. has completed its acquisition of fellow beauty care company Elizabeth Arden. Revlon said late Wednesday that the closing of the transaction, announced in mid-June and valued at about $870 million, came after Elizabeth Arden’s shareholders approved the deal in a vote earlier in the day.